DEA Lists New Chemical Mixes Free from Drug Control Hassles
Published Date: 3/20/2026
Notice
Summary
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
Analyzed Economic Effects
5 provisions identified: 2 benefits, 3 costs, 0 mixed.
Listed preparations exempted from select CSA rules
The DEA accepted applications filed between September 1, 2024 and December 31, 2025 and determined that the specific preparations listed in Chart I are exempt, to the extent described in 21 CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 of the Controlled Substances Act (21 U.S.C. 822-823, 825-829, and 952-954) and 21 CFR 1301.74. The exemptions apply only to the precise preparations and forms described in each application.
Bulk exempt products restricted to in-house use
For exempted bulk products, DEA determined they may only be used in-house by the manufacturer and may not be distributed for any purpose or transported to other facilities. This restriction is intended to limit diversion opportunities for larger bulk quantities.
Changes to prep or name require new application
DEA states that any change in the quantitative or qualitative composition of an exempt preparation, or a change in the trade name or other designation after the application date, requires a new application under 21 CFR 1308.24(h).
Exemption does not remove other CSA/CFR duties
DEA notes that the exemptions are limited to specific sections identified in 21 CFR 1308.24(a) and that all other requirements of the CSA and CFR still apply, including registration as an importer required by 21 U.S.C. 957.
Opportunity to comment by May 19, 2026
Interested persons may submit comments on this order electronically or by mail; comments must be submitted or postmarked on or before May 19, 2026. DEA encourages electronic submissions via Regulations.gov (reference Docket No. DEA-372).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20226, By Grace Inc. Counseling Services; Decision and Order
By Grace Inc. Counseling Services in Baltimore faced losing its DEA license because it didn’t keep good records and lied about its owner’s past drug conviction. After a hearing, the DEA decided to revoke their registration, meaning they can’t legally handle controlled substances anymore. This affects the clinic’s ability to operate and could impact patients relying on their services.
2026-20227, St. Michael's Pharmacy; Decision and Order
St. Michael's Pharmacy in Texas had its DEA license suspended and is facing revocation because it kept filling risky drug prescriptions without fixing obvious warning signs of abuse. This affects the pharmacy’s ability to legally handle controlled substances and could impact patients relying on it. The pharmacy must now deal with these serious legal actions, which started in late 2025 and could lead to permanent closure or fines.
Previous / Next Documents
Previous: 2026-05485, CSX Transportation, Inc.-Discontinuance Exemption-in Cook County, Ill
CSX Transportation is stopping train service on a 1.32-mile rail line in Cook County, Illinois, because no local freight has used it in two years. The change starts April 19, 2026, unless someone steps up to keep it running by March 30. Workers affected by this will get job protections, and rerouting options are ready for any traffic that used the line.
Next: 2026-05487, Fermi America LLC (dba Fermi America); Project Matador Advanced Energy and Intelligence Campus AP1000 Units 1-4, Project Matador Nuclear Units 1-4; Notice of Intent To Conduct Scoping Process and Prepare an Environmental Impact Statement
Fermi America wants to build and run four new advanced nuclear reactors at the Project Matador campus. The Nuclear Regulatory Commission is starting a 30-day public comment period to gather ideas and concerns before deciding if they’ll approve the project. This is a big deal for local communities and the environment, with feedback due by April 20, 2026.